Thalidomide for treatment of patients with chronic graft-versus-host disease.

scientific article

Thalidomide for treatment of patients with chronic graft-versus-host disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11090092

P50authorRainer StorbQ19546769
Frederick R. AppelbaumQ75025725
Wendy LeisenringQ75026076
Hans Joachim DeegQ75039559
Mary E D FlowersQ87982223
P2093author name stringSanders JE
Martin PJ
Nash RA
Witherspoon RP
Anasetti C
Koc S
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectthalidomideQ203174
P304page(s)3995-3996
P577publication date2000-12-01
P1433published inBloodQ885070
P1476titleThalidomide for treatment of patients with chronic graft-versus-host disease
P478volume96

Reverse relations

cites work (P2860)
Q38778387A Canine Model of Chronic Graft-versus-Host Disease
Q35737769A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Q59810122A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801
Q33371639Chronic graft-versus-host disease: Pathogenesis and clinical management.
Q33917187Current issues in chronic graft-versus-host disease
Q37989375Cutaneous graft-versus-host disease--clinical considerations and management
Q37268970Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
Q34077787Failure-free survival after initial systemic treatment of chronic graft-versus-host disease
Q27012940Graft-versus-host disease: why have we not made more progress?
Q34644980Have we made progress in the management of chronic graft-vs-host disease?
Q46428638Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Q39138108Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience
Q26827651National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Q86890944Phase-1/-2 study of pomalidomide in chronic GvHD
Q38416371Prophylactic and therapeutic treatment of graft-versus-host disease in Japan
Q36233448Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study
Q35848933Rituximab for steroid-refractory chronic graft-versus-host disease
Q38416376State-of-the-art acute and chronic GVHD treatment
Q53681955Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.
Q91830004Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn
Q34597832Thalidomide in cancer treatment: a potential role in the elderly?
Q33361034Thalidomide-induced severe neutropenia during treatment of multiple myeloma
Q38121762Therapeutic effects of thalidomide in hematologic disorders: a review
Q37173479Therapy of chronic graft-versus-host disease
Q37371836Treatment and management of graft-versus-host disease: improving response and survival
Q26851433Treatment of chronic graft-versus-host disease in 2011
Q35524687Treatment of chronic graft-versus-host disease: Past, present and future

Search more.